Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,375
Total Claims
$1.0M
Drug Cost
711
Beneficiaries
$1,434
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+71%
Opioid rate vs peers
3.8% vs 2.2% avg
+2%
Cost per patient vs peers
$1,434 vs $1,411 avg
+10%
Brand preference vs peers
11.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.8%
Opioid Rate
475
Opioid Claims
$18K
Opioid Cost
19.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,435 claims · $784K
Generic: 10,864 claims · $223K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 234 | $200K |
| Dapagliflozin Propanediol | 103 | $75K |
| Semaglutide | 45 | $51K |
| Dulaglutide | 36 | $39K |
| Mirabegron | 55 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $28K |
| Empagliflozin | 37 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 21 | $23K |
| Rivaroxaban | 28 | $23K |
| Fluticasone/Umeclidin/Vilanter | 24 | $16K |
| Sitagliptin Phosphate | 14 | $16K |
| Insulin Detemir | 24 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $13K |
| Levothyroxine Sodium | 674 | $12K |
| Sacubitril/Valsartan | 19 | $11K |
Prescribing Profile
Patient Profile
79
Avg Age
57%
Female
1.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About